Name
Medicate Est OÜ
Registry code
11637982
VAT number
EE101297592
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
08.05.2009 (15)
Financial year
01.01-31.12
Capital
40 000.00 €
Activity
47911 - Retail sale via mail order houses or via Internet
52 517 €
24 €
0%
-
38 001 €
1
Submitted
No tax arrears
0%
0%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Martin Saar 30.09.1990 (34) | 75% - 30 000.00 EEK | - | - | |
| Jaanus Saar 12.10.1951 (73) | 25% - 10 000.00 EEK | Board member | Direct ownership | Founder |
| 2019 17.08.2020 | 2020 24.06.2021 | 2021 20.07.2022 | 2022 06.06.2023 | 2023 30.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 91 801 € | 78 487 € | 74 555 € | 59 128 € | 52 517 € |
| Net profit (loss) for the period | 7 860 € | 876 € | 1 414 € | -13 486 € | 24 € |
| Profit Margin | 9% | 1% | 2% | -23% | 0% |
| Current Assets | 52 167 € | 53 073 € | 54 726 € | 40 619 € | 40 907 € |
| Fixed Assets | 1 169 € | 584 € | 0 € | 0 € | 0 € |
| Total Assets | 53 336 € | 53 657 € | 54 726 € | 40 619 € | 40 907 € |
| Current Liabilities | 4 163 € | 3 608 € | 3 263 € | 2 642 € | 2 906 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 49 173 € | 50 049 € | 51 463 € | 37 977 € | 38 001 € |
| Employees | 2 | 2 | 2 | 2 | 1 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 15 030.33 € | 2 249.98 € | 1 095 € | - |
| 2023 Q4 | 14 298.64 € | 1 581.66 € | 1 095 € | - |
| 2023 Q3 | 12 316.56 € | 2 043.72 € | 1 095 € | - |
| 2023 Q2 | 11 660.34 € | 2 629.58 € | 1 095 € | - |
| 2023 Q1 | 15 467.3 € | 2 305.93 € | 895 € | - |
| 2022 Q4 | 13 075.34 € | 3 293.84 € | 1 803.12 € | - |
| 2022 Q3 | 14 456.22 € | 2 590.22 € | 1 442.43 € | 1 |
| 2022 Q2 | 17 230.42 € | 4 101.86 € | 1 564.91 € | 1 |
| 2022 Q1 | 18 234.33 € | 2 924.54 € | 1 626.15 € | 1 |
| 2021 Q4 | 28 937.89 € | 4 391.76 € | 1 626.15 € | 1 |
| 2021 Q3 | 10 709.82 € | 2 959.59 € | 1 626.15 € | 1 |
| 2021 Q2 | 19 405.89 € | 3 720.93 € | 1 626.15 € | 1 |
| 2021 Q1 | 19 401.05 € | 3 826.74 € | 1 626.15 € | 2 |
| 2020 Q4 | 23 497.45 € | 4 240.5 € | 1 626.15 € | 2 |
| 2020 Q3 | 13 483.3 € | 3 168.45 € | 1 449.15 € | 2 |
| 2020 Q2 | 21 215.57 € | 4 418.99 € | 1 626.15 € | 2 |
| 2020 Q1 | 24 288.78 € | 4 404.4 € | 1 626.15 € | 2 |
